Note: Ingredients listed on restricted chemical lists
EC/CAS
50-33-9
Name of the chemical
Phenylbutazone (INN)
Concentration
>55
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
1-10
General Information
Revision date
2023-08-12
Product name
Equipalazone (Oral powder)
Product Synonyms
Phenylbutazone
1.2.1 Relevant identified uses
For the treatment of musculoskeletal disorders in horses and ponies
1.2.2. Uses advised against
Not for human use Reasons why uses advised against: Not determined or not applicable
supplier name
Canada
Icons in SDS
Company Information
company name
Canada
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H312, H315, H317, H319, H332, H334, H335, H351, H361
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Signal word
Danger
Hazard statements
H315 Causes skin irritation H319 Causes serious eye irritation H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 May cause an allergic skin reaction H351 Suspected of causing cancer if inhaled. H361 Suspected of damaging fertility or the unborn child. H335 May cause respiratory irritation H332 Harmful if inhaled H312 Harmful in contact with skin H302 Harmful if swallowed
Precautionary statements
P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood P280 Wear protective gloves, protective clothing, eye protection and face protection. P271 Use only outdoors or in a well-ventilated area P261 Avoid breathing dust. P284 In case of inadequate ventilation wear respiratory protection. P270 Do not eat, drink or smoke when using this product P272 Contaminated work clothing should not be allowed out of the workplace P264 Wash hands thoroughly for 15 minutes after handling. P302+P352 IF ON SKIN: Wash with plenty of water and soap. P361+P364 Take off immediately all contaminated clothing and wash it before reuse P321 Specific treatment (see Sections 4-8 of this SDS and any supplemental information on the product label). P333+P313 If skin irritation or rash occurs: Get medical attention. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P337+P313 If eye irritation persists: Get medical attention. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing P342+P311 If experiencing respiratory symptoms: Call a doctor. P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell P330 Rinse mouth P312 Call a POISON CENTER/doctor if you feel unwell P308+P313 If exposed or concerned: Get medical advice. P405 Store locked up P403+P233 Store in a well-ventilated place. Keep container tightly closed P501 Dispose of contents and container in accordance with local regulations. Hazards not otherwise classified: None
Supplemental label elements
0 percent of the mixture consists of ingredient(s) of unknown acute oral toxicity 0 percent of the mixture consists of ingredient(s) of unknown acute dermal toxicity 0 percent of the mixture consists of ingredient(s) of unknown acute inhalation toxicity
2.1 Classification of the substance or mixture
Acute toxicity (oral), category 4 Acute toxicity (dermal), category 4 Acute toxicity (inhalation), category 4 Skin irritation, category 2 Eye irritation, category 2A Respiratory sensitization, category 1 Skin sensitization, category 1 Carcinogenicity, category 2 Reproductive toxicity, category 2 Specific target organ toxicity - single exposure, category 3, respiratory tract irritation